, Guideline contributors Austria 1
, Belgium, vol.1, issue.21
,
,
,
, French Guiana, vol.1
, Greece ?, vol.41, issue.2
, Guatemala, vol.1, issue.1
,
,
, Lebanon, issue.11
,
,
, United Arab Emirates, vol.1
Case definition of chronic pulmonary aspergillosis in resource-constrained settings):e171312. https, Emerg Infect Dis, vol.24, issue.8, 2018. ,
Cryptococcal Antigen Screening and Preemptive Therapy in Patients Initiating Antiretroviral Therapy in Resource-Limited Settings, Journal of the International Association of Physicians in AIDS Care, vol.53, issue.4, pp.374-379, 2012. ,
DOI : 10.1093/cid/cir379
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline, Clinical Microbiology and Infection, vol.24, issue.1, pp.1-38, 2018. ,
DOI : 10.1016/j.cmi.2018.01.002
URL : https://hal.archives-ouvertes.fr/hal-01953645
Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples, Journal of Infection, vol.77, issue.3, 2018. ,
DOI : 10.1016/j.jinf.2018.05.001
Increased incidence of co-infection in critically ill patients with influenza, Intensive Care Medicine, vol.3, issue.Suppl 2, pp.48-58, 2017. ,
DOI : 10.1016/S2213-2600(15)00278-7
Novel Tests for Diagnosis of Invasive Aspergillosis in Patients with Underlying Respiratory Diseases, American Journal of Respiratory and Critical Care Medicine, vol.189, issue.8 ,
DOI : 10.1097/QCO.0000000000000005
, Am J Respir Crit Care Med, vol.190, issue.8, pp.922-929, 2014.
Fungal Infections and New Biologic Therapies, Current Rheumatology Reports, vol.64, issue.12, p.29, 2016. ,
DOI : 10.1002/acr.21784
Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis, Med Mycol, vol.55, issue.5, pp.528-534, 2017. ,
Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways, Clinical Infectious Diseases, vol.10, issue.1, pp.140-148, 2018. ,
DOI : 10.1371/journal.pone.0137641
The global problem of antifungal resistance: prevalence, mechanisms, and management, The Lancet Infectious Diseases, vol.17, issue.12, pp.383-392, 2017. ,
DOI : 10.1016/S1473-3099(17)30316-X
, Curr Opin Infect Dis, vol.31, issue.4, pp.334-340, 2018.
, Expert Review of Anti-infective Therapy, vol.53, issue.6, pp.1095-1099, 2017.
DOI : 10.1128/AAC.01056-17
Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally, PLOS Pathogens, vol.389, issue.5, p.1006290, 2017. ,
DOI : 10.1371/journal.ppat.1006290.t001
AIDS-Related Endemic Mycoses in Western Cape, South Africa, and Clinical Mimics: A Cross-Sectional Study of Adults With Advanced HIV and Recent-Onset, Widespread Skin Lesions, Open Forum Infectious Diseases, vol.50, issue.4, p.186, 2017. ,
DOI : 10.3109/13693786.2011.596288
a Dimorphic Fungus Causing Fatal Systemic Human Disease in North America, Emerging Infectious Diseases, vol.24, issue.4, pp.758-761, 2018. ,
DOI : 10.3201/eid2404.171765
A Dimorphic Fungus Causing Disseminated Infection in South Africa, New England Journal of Medicine, vol.369, issue.15, pp.1416-1424, 2013. ,
DOI : 10.1056/NEJMoa1215460
Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales) ,
, Mycoses, vol.60, issue.5, pp.296-309, 2017.
Rare Mold Infections Caused by Mucorales, Lomentospora Prolificans and Fusarium , San Diego: The Role of Antifungal Combination Therapy, International Journal of Antimicrobial Agents, 2018. ,
DOI : 10.1016/j.ijantimicag.2018.08.005
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy, Drug Design, Development and Therapy, vol.12, pp.1033-1044, 2018. ,
DOI : 10.2147/DDDT.S145545
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study, Mycoses, vol.26, issue.3, pp.201-205, 2018. ,
DOI : 10.1592/phco.26.12.1730
Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi, The Journal of Infectious Diseases, vol.13, issue.22, pp.474-483, 2017. ,
DOI : 10.1016/S1473-3099(12)70293-1
Nucleic acid amplification methodologies for the detection of pulmonary mold infections, Expert Review of Molecular Diagnostics, vol.4, issue.3, pp.271-279, 2017. ,
DOI : 10.1126/scitranslmed.3005377
Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis, Mycoses, vol.54, issue.Suppl 1, pp.818-825, 2017. ,
DOI : 10.3414/ME14-01-0113
Recent Advances and Ongoing Challenges in the Diagnosis of Microbial Infections by MALDI-TOF Mass Spectrometry, Frontiers in Microbiology, vol.8, p.1097, 2018. ,
DOI : 10.1371/journal.pone.0056139
Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis, Mycoses, vol.70, issue.1, pp.40-43, 2018. ,
DOI : 10.1016/j.jinf.2014.11.005
Improving outcome of fungal diseases - Guiding experts and patients towards excellence, Mycoses, vol.47, issue.Suppl 3, pp.420-425, 2017. ,
DOI : 10.1183/13993003.00583-2015
-Global Emerging Fungal Infection Registry, Mycoses, vol.60, issue.Suppl 3, pp.508-516, 2017. ,
DOI : 10.1111/myc.12595
species: Report of 23 cases from the FungiScope Registry, Mycoses, vol.16, issue.Suppl 7, pp.273-279, 2017. ,
DOI : 10.1016/S1473-3099(16)00071-2
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis, The Lancet Infectious Diseases, vol.16, issue.7, pp.828-837, 2016. ,
DOI : 10.1016/S1473-3099(16)00071-2
ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.5, issue.6, 2018. ,
DOI : 10.1517/14656566.5.2.247
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases, The Lancet Infectious Diseases, vol.15, issue.4, pp.461-474, 2015. ,
DOI : 10.1016/S1473-3099(15)70006-X
The GRADE System for Rating Clinical Guidelines, PLoS Medicine, vol.299, issue.9, p.1000094, 2009. ,
DOI : 10.1001/jama.299.6.646
AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines, BMJ, vol.352, p.1152, 2016. ,
AGREE II: advancing guideline development, reporting and evaluation in health care, Canadian Medical Association Journal, vol.182, issue.18, pp.839-842, 2010. ,
DOI : 10.1503/cmaj.090449
Development of the AGREE II, part 1: performance, usefulness and areas for improvement, Canadian Medical Association Journal, vol.182, issue.10, pp.1045-1052, 2010. ,
DOI : 10.1503/cmaj.091714
Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together, Mycoses, vol.182, issue.10, pp.1-10, 2018. ,
DOI : 10.1503/cmaj.091714
URL : https://hal.archives-ouvertes.fr/hal-01863269